Products - Diabetes | Topic | NICE

Showing 8 products

Date | Sort by Title

Product type: GuidanceRemove ‘Product type: Guidance’ filter
New and updated: New in the last 6 monthsRemove ‘New and updated: New in the last 6 months’ filter

Ertugliflozin with metformin and a dipeptidyl peptidase-4 inhibitor for treating type 2 diabetes (TA583)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published date:
5 June 2019
Ertugliflozin as monotherapy or with metformin for treating type 2 diabetes (TA572)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published date:
27 March 2019
Dapagliflozin, in combination with insulin, for treating type 1 diabetes [ID1478]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
28 August 2019
Diabetic foot infection: antimicrobial prescribing
Status:
In development
Programme:
NICE guideline
Expected publication date:
11 October 2019
Sotagliflozin, in combination with insulin, for treating type 1 diabetes [ID1376]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
18 December 2019
Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema (part review of TA301) [ID1421]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Semaglutide for treating type 2 diabetes (ID1450)
Status:
Proposed
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Ranibizumab for treating diabetic retinopathy [ID1592]
Status:
Proposed
Programme:
Technology appraisal guidance
Expected publication date:
TBC